Clinical Significance of Programmed Death Ligand‑1 and Intra-Tumoral CD8(+) T Lymphocytes in Ovarian Carcinosarcoma

Ovarian carcinosarcoma (OCS) accounts for high mortality and lacks effective therapeutic methods. So far, we lack reliable biomarkers capable of predicting the risk of aggressive course of the disease. Programmed death ligand-1 (PD-L1) is expressed in various tumors, and antibodies targeting its rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jun, Wen, Hao, Ju, Xingzhu, Bi, Rui, Zuo, Wenjia, Wu, Xiaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268655/
https://www.ncbi.nlm.nih.gov/pubmed/28125702
http://dx.doi.org/10.1371/journal.pone.0170879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268655/
https://www.ncbi.nlm.nih.gov/pubmed/28125702
http://dx.doi.org/10.1371/journal.pone.0170879

Ejemplares similares